Y06014 is a selective BET inhibitor for the treatment of prostate cancer

科学数据银行2025-03-20 更新2026-04-23 收录

BET抑制剂

前列腺癌药物研究

数据链接：

https://www.scidb.cn/detail?dataSetId=40e8482671674298b710c8d666e36dca 数据链接链接失效反馈

官方服务：

资源简介：

This zip package includes all the raw data involving in the article "Y06014 is a selective BET inhibitor for the treatment of prostate cancer"submitted to the acta pharmacologica sinica

提供机构：

Zhao-Xuan Liu; Tianbang Wu; Qiuping Xiang; Guangdong Provincial Key Laboratory of Biocomputing, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou Medical University, Guangzhou 510530, China.; Guangdong Provincial Key Laboratory of Biocomputing, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou Medical University, Guangzhou 510530, China. University of Chinese Academy of Sciences, Beijing 100049, China; "Guangdong Provincial Key Laboratory of Biocomputing, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou Medical University, Guangzhou 510530, ChinaBioland Laboratory, Guangzhou 510005, China. State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China. "; Lin-Jiu Xiao

创建时间：

2024-01-09

Y06014 is a selective BET inhibitor for the treatment of prostate cancer

资源简介：

相关数据集